Patrick M. Dillon
Primary AppointmentAssistant Professor,
Dr. Dillon was born in Charleston, SC and attended Furman University in Greenville, SC where he majored in biochemistry. He completed medical school at the University of North Carolina at Chapel Hill. Both his internship and residency training were at the University of Virginia in Charlottesville, VA. His oncology fellowship training was completed at the University of North Carolina at Chapel Hill. During his fellowship training, Dr. Dillon pursued research into mouse models of human cancer, cell signaling, chemotherapy drug delivery, and chemotherapy effects on measures of cellular aging. He also pursued markers of immune privilege in a melanoma cell line. He led three clinical trials while at the University of North Carolina and was trained in clinical trial design.
Dr. Dillon specializes in the treatment of breast cancer and adenoid cystic carcinoma. His current research focuses on immune modulation for treatment of human cancers and he is currently leading a vaccine trial for breast cancer survivors. He also leads clinical trials of chemotherapeutic agents for the treatment of breast cancer and adenoid cystic carcinoma. Dr. Dillon promotes cancer survivorship issues and leads a study of an exercise intervention called Nia for breast cancer survivors. He takes an interest in early and late term side effects of cancer treatments and he is a part of the adenoid cystic carcinoma research team at UVA.